Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney.
Rat kidneys were perfused for 30 min with a Krebs-Henseleit bicarbonate buffer with 5 mM glucose. Albumin proved superior to pluronic polyols as oncotic agent with regard to carnitine reabsorption in the perfused kidney. The reabsorption of 30 microM (-)-[methyl-3 H]carnitine was approx. 96% during the first 10 min. At 750 microM the reabsorption decreased to 40%. The tubular reabsorptive maximum (Tmax) was approx. 170 nmol/min per kidney. The fractional reabsorption and clearance of (+)-carnitine, gamma-butyrobetaine, and carnitine esters did not deviate significantly from that of (-)-carnitine. (+)-Carnitine was not metabolized by the perfused kidney. In perfusions with (-)-carnitine or (-)-carnitine plus 10 mM alpha-ketoisocaproate or alpha-ketoisovalerate increased amounts of acetylcarnitine, isovalerylcarnitine and isobutyrylcarnitine were found. Propionate (5 mM) inhibited acetylcarnitine formation. Isovalerylcarnitine, isobutyrylcarnitine and propionylcarnitine were actively degraded to free (-)-carnitine. In urine, we found a disproportionally high excretion of carnitine or carnitine esters formed in the kidney, compared to the same derivatives when ultrafiltrated. Leakage of metabolites formed in the kidney into preurine may explain this phenomenon.
Hokland
B M
BM
Bremer
J
J
D000042:Absorption; D000108:Acetylcarnitine / Q000378:metabolism; D000418:Albumins / Q000494:pharmacology; D000818:Animals; D002331:Carnitine / Q000031:analogs & derivatives / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D010477:Perfusion; D051381:Rats; D011919:Rats, Inbred Strains
D000418:Albumins; C003223:propionylcarnitine; D000108:Acetylcarnitine; D002331:Carnitine